4D Molecular Therapeutics CLO Scott Bizily disposes of common shares worth $39,567.5
FDMT•Insider share sale and option exercise
- 4D Molecular Therapeutics Chief Legal Officer Scott Bizily exercised stock options on Aug. 13 and Aug. 17 at $4.14.
- Sold 3,270 common shares at $12 and $12.2 on the same dates.
- Directly held 8,617 common shares following the transactions.
